Trials / Completed
CompletedNCT02853916
Efficacy of a Brown Seaweed Powder for Glycemic Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this trial are to confirm efficacy in human of a brown seaweed powder and explore dose-response relationship by comparing two different doses. The primary endpoint is incremental area under the curve (iAUC, mmol\*min/L) for blood glucose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 500 mg InSea2® | |
| DIETARY_SUPPLEMENT | 250 mg InSea2® | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-04-01
- Completion
- 2017-10-25
- First posted
- 2016-08-03
- Last updated
- 2017-10-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02853916. Inclusion in this directory is not an endorsement.